Institut Cancerologie De Louest

We track 3 ClinicalTrials.gov studies led by Institut Cancerologie De Louest. The portfolio skews toward N/A (2 trials).

3 clinical trials sponsored by Institut Cancerologie De Louest.

Pipeline by Phase

PhaseTrialsDistribution
N/A 2
67%
Phase 2 1
33%

Trial Status Breakdown

Trials by Institut Cancerologie De Louest

Prediction in Silico of Pathological Response in a Prospective Cohort Study of Early Breast Cancer Patients

NCT05981326 · RECRUITING · N/A

Detection and Metabolic Characterization in DOPA PET/CT of no Treated Brain Metastases of Lung Cancer, Breast Cancer and Melanoma

NCT04890028 · COMPLETED · N/A

A Randomized Phase II Trial of Stereotactic Body Radiation Therapy (SBRT) With or Without Durvalumab (MEDI4736) in Oligometastatic Recurrent Hormone Sensitive Prostate Cancer Patients

NCT03795207 · ACTIVE NOT RECRUITING · Phase 2

Frequently Asked Questions

How many clinical trials does Institut Cancerologie De Louest sponsor?

Institut Cancerologie De Louest currently sponsors 3 clinical trials tracked on ReadTheTrial. These span N/A, Phase 2.

What conditions does Institut Cancerologie De Louest research?

Institut Cancerologie De Louest conducts research across multiple therapeutic areas. Browse the trial listings for details.

Is Institut Cancerologie De Louest recruiting for clinical trials?

Yes, Institut Cancerologie De Louest currently has 1 trial that are actively recruiting participants. Check individual trial pages for eligibility criteria and locations.

Explore More